Carera Pharma A/S: Financial statements 2023
CVR: 39913046
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Carera Pharma A/S (CVR 39913046) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 999,210 and a net result of DKK -411,785 compared with DKK -2,026,210 the year before. Equity in the 2023 report amounted to DKK -3,091,390. The company had 3 employees in the financial year.
- Gross Profit
- DKK 999,210
- Profit/Loss
- DKK -411,785
- Equity
- DKK -3,091,390
- Total Assets
- DKK 1,274,719
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 999K | -412K | -3.1M | 3 |
| 2022 | - | -318K | -2M | -2.7M | 7 |
| 2021 | - | 1.8M | -607K | -653K | 7 |
| 2020 | - | 2.6M | -278K | -46K | 10 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Carera Pharma A/S has published its annual report for 2022. Gross profit came to DKK -317,584, and the net result was DKK -2,026,210.
About Carera Pharma A/S
Carera Pharma A/S is a Danish company of the type Aktieselskab based in København S, founded in 2018. The company is registered under the industry Engroshandel med andre fødevarer. The company was previously named Yokoso A/S. The management consists of Zengwen Jia. The board consists of Chenglin Gu (chair), Chen Liu and Zengwen Jia. The company is owned by Zengwen Jia. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK -417,453 and a net result of DKK -626,216 compared with DKK -500,690 the year before. Equity in the 2025 report amounted to DKK -4,218,297.